Psoriasis: assessment and management

Overweight and obesity management (2025) NICE guideline NG246

Cardiovascular disease: risk assessment and reduction, including lipid modification (2023) NICE guideline NG238

Tobacco: preventing uptake, promoting quitting and treating dependence (2021) NICE guideline NG209

Type 2 diabetes prevention: population and community-level interventions (2011) NICE guideline PH35

Medicines adherence (2009) NICE guideline CG76

Cardiovascular disease prevention (2010) NICE guideline PH25

Alcohol-use disorders: prevention (2010) NICE guideline PH24

Depression in children and young people (2019) NICE guideline NG134

Ustekinumab for the treatment of adults with moderate to severe psoriasis (2009) NICE technology appraisal guidance 180

Adalimumab for psoriasis (2008) NICE technology appraisal guidance 146

Depression in adults with a chronic physical health problem (2009) NICE guideline CG91

Physical activity for children and young people (2009) NICE guideline PH17

Physical activity in the workplace (2008) NICE guideline PH13

Infliximab for psoriasis (2008) NICE technology appraisal guidance 134

Four commonly used methods to increase physical activity (2006) NICE guideline PH2

Etanercept and efalizumab for psoriasis (2006) NICE technology appraisal guidance 103